期刊文献+

Clinical features and management of primary sclerosing cholangitis 被引量:9

Clinical features and management of primary sclerosing cholangitis
暂未订购
导出
摘要 Primary sclerosing cholangitis is a chronic cholestatic liver disease characterized by inflammation and fibrosis of the bile ducts,resulting in cirrhosis and need for liver transplantation and reduced life expectancy.The majority of cases occur in young and middle-aged men,often in association with inflammatory bowel disease.The etiology of primary sclerosing cholangitis includes immune-mediated components and elements of undefined nature.No effective medical therapy has been identified.The multiple complications of primary sclerosing cholangitis include metabolic bone disease,dominant strictures,bacterial cholangitis,and malignancy,particularly cholangiocarcinoma,which is the most lethal complication of primary sclerosing cholangitis.Liver transplantation is currently the only life-extending therapeutic alternative for patients with end-stage disease,although recurrence in the allografted liver has been described.A PSC-like variant attracting attention is cholangitis marked by raised levels of the immunoglobulin G4 subclass,prominence of plasma cells within the lesions,and steroid responsiveness. Primary sclerosing cholangitis is a chronic cholestatic liver disease characterized by inflammation and fibrosis of the bile ducts,resulting in cirrhosis and need for liver transplantation and reduced life expectancy.The majority of cases occur in young and middle-aged men,often in association with inflammatory bowel disease.The etiology of primary sclerosing cholangitis includes immune-mediated components and elements of undefined nature.No effective medical therapy has been identified.The multiple complications of primary sclerosing cholangitis include metabolic bone disease,dominant strictures,bacterial cholangitis,and malignancy,particularly cholangiocarcinoma,which is the most lethal complication of primary sclerosing cholangitis.Liver transplantation is currently the only life-extending therapeutic alternative for patients with end-stage disease,although recurrence in the allografted liver has been described.A PSC-like variant attracting attention is cholangitis marked by raised levels of the immunoglobulin G4 subclass,prominence of plasma cells within the lesions,and steroid responsiveness.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第21期3338-3349,共12页 世界胃肠病学杂志(英文版)
关键词 Sclerosing cholangitis DIAGNOSIS THERAPY CHOLESTASIS CHOLANGIOCARCINOMA Liver transplantation 胆管炎 硬化 诊断 治疗 胆汁淤积
  • 相关文献

参考文献164

  • 1[1]Lee YM,Kaplan MM.Primary sclerosing cholangitis.N Engl J Med 1995;332:924-933
  • 2[2]Talwalkar JA,Lindor KD.Primary sclerosing cholangitis.Inflamm Bowel Dis 2005;11:62-72
  • 3[3]LaRusso NF,Shneider BL,Black D,Gores GJ,James SP,Doo E,Hoofnagle JH.Primary sclerosing cholangitis:summary of a workshop.Hepatology 2006;44:746-764
  • 4[4]Gautam M,Cheruvattath R,Balan V.Recurrence of autoimmune liver disease after liver transplantation:a systematic review.Liver Transpl 2006;12:1813-1824
  • 5[5]Farrant JM,Hayllar KM,Wilkinson ML,Karani J,Portmann BC,Westaby D,Williams R.Natural history and prognostic variables in primary sclerosing cholangitis.Gastroenterology 1991;100:1710-1717
  • 6[6]Chapman RW,Arborgh BA,Rhodes JM,Summerfield JA,Dick R,Scheuer PJ,Sherlock S.Primary sclerosing cholangitis:a review of its clinical features,cholangiography,and hepatic histology.Gut 1980;21:870-877
  • 7[7]Wiesner RH,Grambsch PM,Dickson ER,Ludwig J,MacCarty RL,Hunter EB,Fleming TR,Fisher LD,Beaver SJ,LaRusso NF.Primary sclerosing cholangitis:natural history,prognostic factors and survival analysis.Hepatology 1989;10:430-436
  • 8[8]Wiesner RH,LaRusso NF.Clinicopathologic features of the syndrome of primary sclerosing cholangitis.Gastroenterology 1980;79:200-206
  • 9[9]Broome U,Olsson R,Loof L,Bodemar G,Hultcrantz R,Danielsson A,Prytz H,Sandberg-Gertzen H,Wallerstedt S,Lindberg G.Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.Gut 1996;38:610-615
  • 10[10]Okolicsanyi L,Fabris L,Viaggi S,Carulli N,Podda M,Ricci G.Primary sclerosing cholangitis:clinical presentation,natural history and prognostic variables:an Italian multicentre study.The Italian PSC Study Group.Eur J Gastroenterol Hepatol 1996;8:685-691

同被引文献18

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部